H.R. 4702 · 118th Congress · House

Securing Gene Synthesis Act

Active· Referred to the Subcommittee on Health.
Introduced
Jul 18, 23
Passed House
Pending
Passed Senate
Pending
Sent to President
Pending
Signed into Law
Pending

Executive Summary

Securing Gene Synthesis Act

This bill requires the Department of Health and Human Services to issue regulations to prevent the misuse of de novo gene synthesis products (i.e., manufactured gene products), including screening protocols for providers of these products. Federal agencies and entities that receive federal funds may only purchase such products from providers that comply with the screening protocols.

Action Timeline

4
  1. JUL 21, 2023Committee

    Referred to the Subcommittee on Health.

  2. JUL 18, 2023IntroReferral

    Introduced in House

  3. JUL 18, 2023IntroReferral

    Introduced in House

  4. JUL 18, 2023IntroReferral

    Referred to the House Committee on Energy and Commerce.

Committees

2

Health Subcommittee

hsif14

Referred: Jul 21, 2023

Active

Energy and Commerce Committee

hsif00

Referred: Jul 18, 2023

Active